Salem N Maaliki, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 401 9th Ave Nw, Watertown, SD 57201 Phone: 605-882-7953 Fax: 605-882-7954 |
Dr. Ravishankar V Kalaga, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 401 9th Ave Nw, Watertown, SD 57201 Phone: 605-882-7000 Fax: 605-882-7607 |
Steven E Miller, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 401 9th Ave Nw, Watertown, SD 57201 Phone: 605-882-7953 Fax: 605-882-7954 |
Dr. Michael S Fenster, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 401 9th Ave Nw, Watertown, SD 57201 Phone: 605-882-7953 Fax: 605-882-7954 |
News Archive
In the November 1st issue of G&D, a team of scientists led by Dr. Anil Rustgi (UPENN) presents an innovative new model of esophageal cancer, which holds great promise as an experimental platform to investigate the etiology and possible treatment of this devastating disease.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat serious acute cardiovascular disorders and infectious diseases, has received a grant in the amount of $150,000 from the National Science Foundation to support the development of antimicrobial sutures. PolyMedix has developed a series of novel antimicrobial polymers for device and material applications, which it collectively calls the PolyCides™.
Multiple sclerosis patients who directly confronted the stress of the Second Lebanon War suffered fewer attacks than those who chose to cope with the situation by focusing on feelings. This has been shown in a new study carried out by researchers of the University of Haifa, the Technion-Israel Institute of Technology and Carmel Medical Center.
Acute respiratory infections (ARIs) - such as influenza, pneumonia and respiratory syncytial virus (RSV) - cause 4.25 million deaths each year often among young children in developing countries, according to the Acute Respiratory Infections Atlas, which was released on Tuesday by the World Lung Foundation, Reuters reports (11/9).
Eli Lilly and Company today announced encouraging results from a one-year pilot study examining the effect of ruboxistaurin mesylate in persons with type 2 diabetes and kidney disease (also known as "diabetic nephropathy").
› Verified 2 days ago